Skip to main content

Biological Response Modifiers

  • Chapter
Cancer Chemotherapy: an Introduction

Abstract

In 1906 Paul Ehrlich observed that when a cancer was transplanted from one animal to another of the same species, it failed to grow, and was apparently destroyed by the new host. This was interpreted as evdence that immune mechanisms could lead to tumour rejection. The animals studied were not, however, genetically similar and thus what Ehrlich had recorded was the general phenomenon of transplant rejection rather than a specific antitumour effect. Despite this setback the possibility of stimulating the host’s own defences to recognise malignant tissue as foreign and bring about its destruction has been vigorously pursued over the years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Biological response modifiers. Pinsky CM (editor) (1986) Seminars in Oncology, 13: 131–258

    Google Scholar 

  • Immunotherapy of cancer: the end of the beginning? Durant JR (1987) New England Journal of Medicine, 316: 938–940

    Article  Google Scholar 

  • Lymphokines. Dinarello C, Mier J (1987) New England Journal of Medicine 317: 940–945

    Article  PubMed  CAS  Google Scholar 

  • Human interferon as a therapeutic agent: a decade passes. Merigan TC (1988) New England Journal of Medicine, 318:1458–1460

    Article  PubMed  CAS  Google Scholar 

  • Clinical overview of alpha interferon: studies and future directions. Spiegel RJ (1987) Cancer, 59: 626–631

    Article  PubMed  CAS  Google Scholar 

  • Genes and cancer: a clinical perspective. Ellis M, Sikora K (1987) Journal of the Royal College of Physicians, 21:122–128

    CAS  Google Scholar 

  • Proto-oncogenes and human cancer. Slamon D (1987) New England Journal of Medicine, 317: 955–957

    Article  PubMed  CAS  Google Scholar 

  • Tumour growth factors. Stroobant P (1986) Cancer Topics, 5: 128–129

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Priestman, T.J. (1989). Biological Response Modifiers. In: Cancer Chemotherapy: an Introduction. Springer, London. https://doi.org/10.1007/978-1-4471-1686-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1686-8_10

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-19551-1

  • Online ISBN: 978-1-4471-1686-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics